Results 171 to 180 of about 1,605,382 (377)

Results from a UK consensus about the optimal prescribing of medium strength triple therapy in uncontrolled adult asthma patients in the NHS

Journal of Family Medicine and Primary Care
Context: An inhaled corticosteroid (ICS) in combination with a long-acting β2-agonist (LABA) is a common treatment approach for asthma patients not controlled on ICS alone, but a significant proportion of patients remain uncontrolled on this combination ...
Richard E. K. Russell, Darush Attar-Zadeh, Natalie Harper, Fiona Mosgrove, Laura Rush, Dave Singh   +5 more
doaj   +1 more source

Our contribution to systematic review and meta-analysis in primary care respiratory medicine. [PDF]

NPJ Prim Care Respir Med, 2023
Maricoto T, Tsiligianni I.
europepmc   +1 more source

—An outstanding doctor of integrative medicine on respiratory diseases [PDF]

, 2001
Jianzhong Xu
openalex   +1 more source

Stop Thinking! I Can't! Do Attentional Mechanisms Underlie Primary Dysfunctional Breathing?

Frontiers in Physiology, 2018
Laís S. Vidotto, Marcelo Bigliassi, Mandy O. Jones, Alex Harvey, Celso R. F. Carvalho   +4 more
doaj   +1 more source

Position statement of the Indian Chest Society on reinstatement of the Respiratory Medicine department in undergraduate medical colleges in India. [PDF]

Lung India, 2023
Munje R, Chawla R, Chetambath R, Christopher DJ, Dhar R, Ghoshal AG, Gupta N, Haldar I, Khilnani GC, Koul PA, Mishra G, Mohan A, Nene A, Paramez A, Pothal S, Roy DJ, Salvi SS, Samaria JK, Swarnakar R.   +18 more
europepmc   +1 more source

Handling rescue therapy in myasthenia gravis clinical trials: why it matters and why you should care

Annals of Clinical and Translational Neurology, EarlyView.
Abstract Myasthenia gravis (MG) clinical trials typically allow rescue therapy during follow‐up in the event of marked worsening of MG symptoms. Failure to appropriately address rescue therapy in defining treatment effects and planning statistical analyses may yield biased estimates, increase false positive rates, or decrease statistical power – all of
Justin M. Leach, Inmaculada Aban, Gary Cutter, Michael Benatar   +3 more
wiley   +1 more source

Knowledge and awareness of nicotine, nicotine replacement therapy, and electronic cigarettes among general practitioners with a special interest in respiratory medicine in China. [PDF]

Front Med (Lausanne), 2023
Zhong Q, An K, Wu Z, Zhang H, Li S, Zhang L, Li C, Li H, Zhuo Ga QM, Yang Zong J, An Z.   +10 more
europepmc   +1 more source

Exhaled nitric oxide (NO) levels in steady state bronchiectasis: a prospective systematic study [PDF]

, 2000
Session - Respiratory & Critical Care Medicine: no.
Chan, S, Fung, PCW, Ho, JCM, Ip, S, Lam, CL, Lam, WK, Leung, RYH, Shum, IHY, Tsang, KWT, Zheng, L   +9 more
core  

If it does not help, it might hurt: Pharmacodynamics of a second IVIg course in Guillain–Barré syndrome

Annals of Clinical and Translational Neurology, EarlyView.
Abstract Objectives Intravenous immunoglobulin (IVIg) is an effective treatment for Guillain–Barré syndrome (GBS), but recovery varies between patients. This study aims to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of a single and a second IVIg dose (SID) in patients with GBS.
Sander J. van Tilburg, Ruth Huizinga, Krista Kuitwaard, Sebastiaan D.T. Sassen, Christa Walgaard, Pieter A. van Doorn, Bart C. Jacobs, Birgit C.P Koch   +7 more
wiley   +1 more source

Advances in Respiratory Medicine (ARM)-Past, Present, Future. [PDF]

Adv Respir Med, 2022
Barczyk A.
europepmc   +1 more source